Home / Stocks / TECH

Bio-Techne (TECH, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued

Bio-Techne (TECH, Life Sciences Tools & Services) trades at a blended P/E of 37.1, about 13% above its historical normal valuation, with a forward growth estimate of 11.8% and a PEG of 3.14. Analysts' one-year estimates have been hit 55% of the time.

DATA AS OF 2026-08-21
Blended P/E
37.1
Normal P/E
32.8
PEG
3.14
Fwd growth
11.8%
Div yield
0.4%
RSI (14)
69.1
Neutral

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-03.

Price and rating by weekClose moved +42.4 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Significantly overvalued, close 50.85 (recalculated)2026-06-10: Significantly overvalued, close 52.50 (recalculated)2026-06-14: Significantly overvalued, close 54.00 (recalculated)2026-06-16: Significantly overvalued, close 56.03 (recalculated)2026-06-21: Significantly overvalued, close 57.94 (recalculated)2026-07-02: Significantly overvalued, close 70.83 (recalculated)2026-07-06: Significantly overvalued, close 70.92 (recalculated)2026-07-09: Significantly overvalued, close 71.15 (recalculated)2026-07-12: Significantly overvalued, close 71.30 (recalculated)2026-07-13: Significantly overvalued, close 71.36 (recalculated)2026-07-14: Significantly overvalued, close 71.23 (recalculated)2026-07-20: Significantly overvalued, close 71.64 (recalculated)2026-07-22: Significantly overvalued, close 71.78 (recalculated)2026-07-25: Significantly overvalued, close 71.60 (recalculated)2026-07-27: Significantly overvalued, close 71.62 (recalculated)2026-07-31: Significantly overvalued, close 72.09 (recalculated)2026-08-03: Significantly overvalued, close 72.092026-08-07: Significantly overvalued, close 72.29 (recalculated)2026-08-10: Significantly overvalued, close 72.292026-08-14: Significantly overvalued, close 72.40 (recalculated)2026-08-17: Significantly overvalued, close 72.4051722026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 26.4-18%Significantly overvalued
2026-06-10P/E 27.0-16%Significantly overvalued
2026-06-14P/E 27.0-16%Significantly overvalued
2026-06-16P/E 27.0-16%Significantly overvalued
2026-06-21P/E 27.0-16%Significantly overvalued
2026-07-02P/E 37.0+14%Significantly overvalued
2026-07-06P/E 36.9+14%Significantly overvalued
2026-07-09P/E 36.9+14%Significantly overvalued
2026-07-12P/E 37.1+15%Significantly overvalued
2026-07-13P/E 37.1+15%Significantly overvalued
2026-07-14P/E 37.1+15%Significantly overvalued
2026-07-20P/E 37.5+16%Significantly overvalued
2026-07-22P/E 37.5+16%Significantly overvalued
2026-07-25P/E 37.1+15%Significantly overvalued
2026-07-27P/E 37.1+15%Significantly overvalued
2026-07-31P/E 37.3+15%Significantly overvalued
2026-08-03P/E 37.4+15%Significantly overvalued
2026-08-07P/E 37.2+15%Significantly overvalued
2026-08-10P/E 37.4+16%Significantly overvalued
2026-08-14P/E 37.1+13%Significantly overvalued
2026-08-17P/E 37.2+14%Significantly overvalued
2026-08-21P/E 37.1+13%Significantly overvalued ← now

Frequently asked questions

Is Bio-Techne stock overvalued?

At a blended P/E of 37.1 versus its historical normal P/E of 32.8, Bio-Techne trades about 13% above its typical valuation, with a PEG of 3.14 on 11.8% forward growth. tickerseer currently rates it significantly overvalued.

What is Bio-Techne's fair value and PEG?

Bio-Techne trades at a blended P/E of 37.1 against a historical normal P/E of 32.8, a PEG of 3.14, and a forward growth estimate of 11.8%.

Has tickerseer's rating of Bio-Techne changed?

tickerseer's rating has been significantly overvalued since 2026-06-03.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track TECH free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.